Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of a dose-escalation Phase 1/2 trial of evofosfamide (TH-302) in combination with doxorubicin for soft tissue sarcoma, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• TH-302 (evofosfamide)

Snippet

Sponsor: ImmunoGenesis | Conditions: Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-09-25